Stay updated on Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision label v3.6.6 was added and the previous v3.6.5 was removed, affecting only the page's metadata.
    Difference
    0.1%
    Check dated 2026-08-29T20:38:52.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The platform revision label on the page has been updated to v3.6.5, replacing the previous v3.6.4.
    Difference
    0.0%
    Check dated 2026-08-08T11:16:21.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now displays revision: v3.6.4, indicating a recent update to the page's revision metadata. This does not appear to alter the study information or layout.
    Difference
    0.0%
    Check dated 2026-07-25T07:34:35.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.3 instead of v3.6.2, indicating a small update to the page's template or presentation. The update does not alter the study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-03T22:09:04.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2, reflecting a minor update to the page's template or data handling. This change does not signify a substantive update to the study content.
    Difference
    0.0%
    Check dated 2026-06-26T20:00:56.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    The page now shows a 'No longer looking for participants' status update indicating recruitment is closed. New help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') were added, the header 'Intervention / Treatment' was normalized to 'Intervention/Treatment', and the revision label updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T12:23:25.000Z thumbnail image

Stay in the know with updates to Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.